|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: BB&T CORP, S-4/A, EX-99.A, 2000-12-05 |
Next: MERIDIAN MEDICAL TECHNOLOGIES INC, DEF 14A, 2000-12-05 |
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION |
|||
| Washington, D.C. 20549
|
|||
| SCHEDULE 13D | |||
| Under the Securities Exchange Act of 1934 | |||
|
(Amendment No. 1) |
|||
|
CHEVRON CORPORATION |
|||
| (Name of Issuer) | |||
|
Common Stock, $0.75 par value |
|||
| (Title of Class of Securities) | |||
|
|
|||
| 1667511 | |||
| (Cusip Number) | |||
| TEXACO INC. | |||
| (Name of Persons Filing Statement) | |||
| Deval L. Patrick
Vice President and General Counsel Texaco Inc. 2000 Westchester Avenue White Plains, NY 10650 Tel No.: 914-253-4061 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
|
||
Copy to: Dennis S. Hersch, Esq. Davis Polk & Wardwell 450 Lexington Avenue New York, New York 10017 (212) 450-4000 October 15, 2000
|
|||
|
|
|||
| If the
filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing
this statement because of 13(d)-1(e), 13d-1(f) or 13d-1(g), check the following:o
|
|||
| Texaco Inc. ("Texaco") hereby
amends and supplements its Report on Schedule 13D, originally filed on
October 25, 2000 (the "Schedule 13D") with respect to the acquisition by
Texaco of an option to purchase the common stock, par value $0.75 of Chevron
Corporation ("Chevron").
Cover Page. The responses set forth in disclosure items 7, 9 and 11 of the Schedule 13D cover page are hereby amended and restated as follows: (7) 127,002,000 (9) 127,002,000 (11) 127,002,000
Item 2. Identity and Background. Appendix A to the Schedule 13D (referenced in Items 2 and 5 of the Schedule 13D) is hereby deleted in its entirety and replaced with the Appendix A attached to this Amendment No. 1. Item 5. Interest in Securities of the Issuer. The response set forth on Appendix B to the Schedule 13D (referenced in Item 5 of the Schedule 13D) is hereby amended by adding the following new paragraph at the end of the first paragraph: Robin B. Smith, a Director of Texaco, is the beneficial owner of 2,000 shares of Chevron common stock. These shares were acquired more than 60 days prior to October 25, 2000, the date of filing of the Schedule 13D to which this Appendix B is attached. Texaco expressly disclaims beneficial ownership of these shares. |
| SIGNATURES | |
| After reasonable inquiry and to the best
knowledge and belief of the undersigned, the undersigned certifies that
the information set forth in this statement is true, complete and correct.
Date: December 5, 2000 |
|
| TEXACO INC.
By: /s/ Michael H. Rudy
|
|
| Appendix A | |
| DIRECTORS AND EXECUTIVE OFFICERS OF TEXACO INC. | |
|
The name, title, present principal occupation or employment, and business address of each of the directors and executive officers of Texaco Inc. are set forth below. Unless otherwise indicated, the business address for each person is c/o Texaco Inc., 2000 Westchester Avenue, White Plains, New York, 10650. |
|
| Name
|
Title, Present Principal
Occupation
or Employment and Citizenship |
| A. Charles Baillie | Director. Chairman & Chief Executive Officer of Toronto-Dominion Bank. Toronto-Dominion Bank, 55 King Street West, 11th Floor, Toronto Dominion Bank Tower, Toronto, Ontario M5K 1A2, Canada. Mr. Baillie is a citizen of Canada. |
| Peter I. Bijur | Director. Chairman & Chief Executive Officer of Texaco Inc. |
| Mary K. Bush | Director. President of Bush & Company. Bush & Company, 4201 Cathedral Avenue, N.W., Suite 1016E, Washington, D.C. 20016. |
| Edmund M. Carpenter | Director. President & Chief Executive Officer of Barnes Group, Inc. Barnes Group, Inc., 123 Main Street, P.O. Box 489, Bristol, CT 06011-0489. |
| Robert J. Eaton | Director. Former Chairman of DaimlerChrysler Corporation. DaimlerChrysler Corporation, 1000 Chrysler Dr., CIMS 480-01-01, Auburn Hills, MI 48326-2766. |
| Michael C. Hawley | Director. Former Chairman & Chief Executive Officer of The Gillette Company. The Gillette Company, Prudential Tower Building, 800 Boylston Street, Boston, MA 02119-8004. |
| Franklyn G. Jenifer | Director. President of the University of Texas at Dallas. University of Texas at Dallas, 2601 North Floyd Road, Room AD2.418, Richardson, TX 75080. |
| Sam Nunn | Director. Senior Partner of King & Spalding. King & Spalding, 191 Peachtree Street, Atlanta, GA 30303-1763. |
| Charles H. Price, II | Director. Former Chairman of Mercantile Bank of Kansas City. Mercantile Bank of Kansas City, One West Armour Blvd., Suite 300, Kansas City, MO 64111. |
| Charles R. Shoemate | Director. Advisory Director of Unilever PLC. Unilever PLC, P.O. Box 68, Unilever House, Blackfriars, London EC4P 4BQ, United Kingdom. |
| Robin B. Smith | Director. Chairman & Chief Executive Officer of Publishers Clearing House. Publishers Clearing House, 382 Channel Drive, Port Washington, NY 11050. |
| William C. Steere, Jr. | Director. Chairman & Chief Executive Officer of Pfizer Inc. Pfizer Inc., 235 East 42nd Street, New York, NY 10017-5755. |
| Thomas A. Vanderslice | Director. President of TAV Associates. TAV Associates, Le Rivage, Unit 10-N, 4351 Gulf Shore Blvd. North, Naples, FL 34103. |
| Patrick J. Lynch | Senior Vice President & Chief Financial Officer. |
| John J. O'Connor | Senior Vice President |
| William M. Wicker | Senior Vice President |
| Bruce S. Applebaum | Vice President. 4800 Fournace Place, Bellaire, TX 77401-2324 |
| John S. Bethancourt | Vice President. |
| Eugene Celentano | Vice President. |
| James F. Link | Vice President. |
| James R. Metzger | Vice President. |
| Rosemary Moore | Vice President. |
| Robert C. Oelkers | Vice President. |
| Deval L. Patrick | Vice President & General Counsel. |
| Elizabeth P. Smith | Vice President. |
| Robert A. Solberg | Vice President. 1111 Bagby Street, Houston, TX 77002-2543 |
| Janet L. Stoner | Vice President. |
| Michael N. Ambler | General Tax Counsel. |
| George J. Batavick | Comptroller. |
| Ira D. Hall | Treasurer. |
| Michael H. Rudy | Secretary. |
|
|